Doctor of Osteopathy Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Alexander Dydyk

Pain Medicine Avondale, AZ Doctor of Osteopathy

NPI 1912435694 CMS profile 7620743

13026 W Rancho Santa Fe Blvd Ste C100, Avondale, AZ 85392

Open in the dashboard

General payments

$20,922

310 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexander Dydyk of Avondale, AZ is reported in the CMS Open Payments database as having received $20,922 across 310 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,637 84
2024 General $3,240 56
2023 General $2,339 56
2022 General $9,051 90
2021 General $1,504 18
2020 General $151 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexander Dydyk
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Alexander Dydyk were reported at $4,637. Among 757 Pain Medicine profiles paid that year, the median was $470 and the middle half received between $146 and $1,462.

Show as a table
Year Alexander Dydyk Pain Medicine median Middle half National median
2019 $0 $506 $144–$1,566 $163
2020 $151 $315 $96–$934 $114
2021 $1,504 $452 $134–$1,237 $132
2022 $9,051 $475 $124–$1,407 $149
2023 $2,339 $480 $136–$1,384 $160
2024 $3,240 $521 $164–$1,511 $164
2025 $4,637 $470 $146–$1,462 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medtronic, Inc. $10,045 120 payments
  2. Abbott Laboratories $3,387 34 payments
  3. Boston Scientific Corporation $2,565 29 payments
  4. Spinal Simplicity, LLC $1,344 13 payments
  5. Nalu Medical, Inc. $502 10 payments
  6. Foundation Fusion Solutions, LLC $385 18 payments
  7. SPR Therapeutics, Inc $339 5 payments
  8. Novo Nordisk Inc $317 17 payments
  9. Nevro Corp. $295 8 payments
  10. AngioDynamics, Inc. $197 2 payments
  11. Other $1,545 54 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $12,169 253 payments
  2. Travel and Lodging $8,727 56 payments
  3. Entertainment $26 1 payment
Products named General payments · program years 2020–2025
  1. INTELLIS ADAPTIVESTIM $2,873 31 payments
  2. PROCLAIM $2,360 17 payments
  3. VANTA ADAPTIVESTIM $1,962 11 payments
  4. SYNCHROMEDII $1,637 22 payments
  5. INCEPTIV $1,592 30 payments
  6. Superion Indirect Decompression System $1,521 12 payments
  7. HA MINUTEMAN G3-R $1,344 13 payments
  8. INTELLIS $842 7 payments
  9. LIBERTY SI $521 2 payments
  10. Nalu Neurostimulation System $502 10 payments
  11. Other $5,500 132 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

310 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record